Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.82 USD | +0.35% | +0.42% | +12.25% |
May. 13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
May. 10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.25% | 1.66B | |
+8.64% | 114B | |
+10.33% | 104B | |
-12.69% | 22.41B | |
-0.41% | 22.28B | |
-5.80% | 19.07B | |
-37.36% | 18B | |
-5.36% | 17.89B | |
+6.83% | 14.28B | |
+36.31% | 12.55B |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Transcript : Soleno Therapeutics, Inc. - Shareholder/Analyst Call